Cargando…
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
Over the past few decades, the enhanced permeability and retention (EPR) effect of nanomedicine has been a crucial phenomenon in targeted cancer therapy. Specifically, understanding the EPR effect has been a significant aspect of delivering anticancer agents efficiently to targeted tumors. Although...
Autores principales: | Kim, Jinseong, Cho, Hanhee, Lim, Dong-Kwon, Joo, Min Kyung, Kim, Kwangmeyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298311/ https://www.ncbi.nlm.nih.gov/pubmed/37373227 http://dx.doi.org/10.3390/ijms241210082 |
Ejemplares similares
-
Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
por: Cho, Hanhee, et al.
Publicado: (2021) -
Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery
por: Dhaliwal, Alexander, et al.
Publicado: (2019) -
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
por: Shi, Yang, et al.
Publicado: (2020) -
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022) -
EPR Effect-Based Tumor Targeted Nanomedicine: A Promising Approach for Controlling Cancer
por: Fang, Jun
Publicado: (2022)